Open company graph database — free web & API
Login

Medii Co., Ltd.

株式会社Medii
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
48
Related companies
13
§01

Basic information

BASIC
Head office
4F, THE PORTAL Shinjuku Gyoen, 1-23-1 Shinjuku, Shinjuku-ku, Tokyo 160-0022
Chief executive
Yutaka Yamada
Capital
100,000,000
Employees (non-consolidated)
48 people
Employees (consolidated)
Start date
2020-02-20
End date
§02

Websites

1 DOMAINS
§03

Business

4
Operation of a clinical question resolution platform for physiciansAI search service "Medii Q"Specialist consultation service "Medii E-Consult"Marketing support for pharmaceutical companies
§04

Related companies

13 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
First CVC Inc.
Group Parent
日本神経免疫学会
Customer
骨系統疾患コンソーシウム
Customer
Amgen Inc.
Alliance
Nobel Pharma Co., Ltd.
Alliance
Pfizer Inc.
Alliance
協和キリン
Alliance
日本ベーリンガーインゲルハイム
Alliance
日経メディカル
Alliance
Asahi Kasei Therapeutics Co., Ltd.
Alliance
ANRI
Shareholder
FTI
Shareholder
GCP Chemicals Inc.
Shareholder
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

2 EVENTS

Research team "Visualization of unmet medical needs for rheumatoid disease from the patient perspective and research contributing to social implementation" funded by the Ministry of Health, Labour and Welfare for FY2024Sources

Completed pediatric specialist training at Showa University and graduated from the School of Public Health, University of Hawaii in 2025Sources

§07

News

39 ARTICLES

Notice Regarding Unauthorized Access to KARTESources

The unauthorized access to KARTE disclosed by Playd Inc. also affected Medii's physician platform. The leaked information included the name of the employer medical institution, prefecture, and member number, but did not contain passwords. Some personal data such as name, email address, and date of birth were also transmitted, so Playd is continuing its investigation. Affected members will be contacted individually by email.

Exhibit at the 46th Medical Informatics Federation ConferenceSources

Medii Inc. will exhibit a booth at the 46th Medical Informatics Federation Conference held in Sapporo from November 12 to 15, 2026, and introduce AI search for physicians, "Medii Q", among other products. During the Hyper Demo on November 14, COO Ryosuke Tsutsui will speak, demonstrating Medii Q and discussing its implementation in medical institutions.

Medii COO Tsutsui Speaks at Joint Event with Three CompaniesSources

Medii Co., Ltd. is co-hosting a real event for pharmaceutical companies titled "How to Capture Doctors' Honest Opinions with Data and AI" with Harmo Co., Ltd. and BIGM2Y Co., Ltd. At both days, COO Tsutsui will speak in a joint lecture, discussing the theme of an era where doctors' decision-making becomes invisible. The event will be held on November 19 and 26, and participation is free.

Interview Article with Solution Team Leader Morita Featured in Social Business EncyclopediaSources

An interview article with Solution Team Leader Morita was published in the official note series "Social Business Encyclopedia" of the multi-job transition service "Socialia." The article discusses Morita's transition from a consulting firm to Medii, his dedication to project management, and his sense of fulfillment in his work.

Presented Two Analyses of Case Consultations at the Japanese Society of Neurological ImmunologySources

Two analyses based on case consultations received by Medii E-Consult’s "MS/NMOSD/MOGAD Consultation Desk" and "MG Consultation Desk" were presented at the 38th Annual Scientific Meeting of the Japanese Society of Neurological Immunology. The presentations covered a comparison of clinical practices for myasthenia gravis (MG) and an analysis of 441 online consultations for neuro‑immune diseases via the DtoD platform.

Interview with Representative Yamada Featured in 'Monthly QOL VIEW'Sources

An interview article with Yamada, the representative of Medii, was published in the November 2026 issue (No.17) of the comprehensive medical information magazine 'Monthly QOL VIEW'. The magazine is distributed nationwide to hospitals and clinics, and it can also be purchased on the Medical Quality Co. website.

Medii Pharma Report 2026 First HalfSources

In this issue, we report the results of an analysis of the difficulty doctors face in judging immune-related adverse events (irAEs) caused by immune checkpoint inhibitors, based on data obtained from the physician-oriented specialist consultation service "Medii E-Consult". The analysis revealed that doctors are more confused at the stage of determining whether symptoms are irAEs and deciding on treatment policy, rather than at the guideline- or material-based decisions on drug discontinuation or continuation. In the future, we will launch a regular report aimed at providing information to pharmaceutical companies based on these analysis results.

Medii was introduced at FastGrowSources

In the FastGrow feature "Beyond Business Development", Medii was introduced. It summarizes the mechanism and business model of Medii E-Consult, starting with President Yamada's original experience. It demonstrates a stance to optimize diagnosis and treatment through a network of 2,000 people, addressing the issue of uneven distribution of specialists.

Notification of Unauthorized Access to Studio ServiceSources

Due to unauthorized access reported by Studio Inc., information submitted via the Medii corporate website contact form (from February 20, 2023 to December 27, 2024) may have been leaked externally. Since Studio has not been using the form function after December 28, 2024, inquiries made after that date are excluded. No tampering or deletion of data has been confirmed, and investigation is underway to determine whether secondary damage has occurred. Please refer to Studio's announcement for details.

RISBOX features collaboration with Hokkaido University Hospital Hematology DepartmentSources

The collaboration with the Hematology Department of Hokkaido University Hospital was featured on RISBOX, operated by Iyaku Keizai Co. Medii has built a hematopoietic stem cell transplantation network on "Medii E-Consult" that connects the Hokkaido University Hospital Hematology Department with local medical institutions. Membership registration is required to view the article.

§08

Public records

GOV
National Tax Agency basic information7011101090575
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
株式会社Medii
Trade name (kana)
メディ
Name in English
Corporation type
301
Address
〒160-0022 東京都新宿区新宿1丁目23番1号
Postal code
1600022
Prefecture code
13
City code
104
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2020-03-02
Update date
2025-08-06
Change date
2025-07-04
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
12
Correction type
0
Trade name image ID
Address image ID
Sequence number
2251586
METI gBizINFO7011101090575
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
7011101090575
Trade name
株式会社Medii
Trade name (kana)
メディ
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
東京都新宿区新宿1丁目23番1号
Postal code
1600022
Prefecture
東京都
Prefecture code
13
City or district
新宿区
City code
104
Street address
新宿1丁目23番1号
Organisation type
301
Processing type
12
Correction type
0
Status
Representative
Capital
Employees
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2025-08-06
Key information
7011101090575
§09

Sources & updates

SOURCES
↑